The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
In this three-part series, Lisa Tonkinson and Chris Wiekert discuss how the Revenue Cycle can impact your supply chain when embarking on a new soft
On-Demand Educational Webinars
Learn about the strategies that have been successful at Dignity Health in developing a purchased services product line. In this webinar we explain…
Webcast
in this short video webcast, Mike Schiller, Senior Director, AHRMM and Dennis Othman, Senior Director, SMI discuss the four key pillars of knowledg
Podcasts
In this three-part webcast, Howard Mann, Vice President, Supply Chain Management at Cardiovascular Care Group discusses the basics and relationship
On-Demand Educational Webinars
This webinar gives a brief overview of the ISM Report On Business, one of the most reliable near-term economic barometers available, and explains why…
Podcasts
A thought-leader panel discussion about the role of GPOs within the changing healthcare landscape and the and the daily decision of using a GPO or